Can a common migraine drug ease Kids' pain? new trial aims to find out
NCT ID NCT07354126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two medicines, flunarizine and propranolol, to see which works better at reducing migraine attacks in children aged 8 to 15. The trial will enroll 44 kids who have frequent migraines and measure improvement using a special disability score. The goal is to find a safe and effective option to ease migraine symptoms in young patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Children's Hospital Lahore
RECRUITINGLahore, Punjab Province, 54600, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?